BDBM557885 1-(4-((4-((3-(hydroxy- methyl)phenyl)amino)-7- methoxyquinazolin-6-yl)- oxy)piperidin-1-yl)prop-2- en-1-one::US11365189, Ex. No. 21

SMILES COc1cc2ncnc(Nc3cccc(CO)c3)c2cc1OC1CCN(CC1)C(=O)C=C

InChI Key InChIKey=JFKBMRPEGXZGJS-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 557885   

TargetEpidermal growth factor receptor(Human)
University Of Texas

US Patent
LigandPNGBDBM557885(US11365189, Ex. No. 21 | 1-(4-((4-((3-(hydroxy- me...)
Affinity DataIC50: 6.80E+3nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [S768I](Human)
University Of Texas

US Patent
LigandPNGBDBM557885(US11365189, Ex. No. 21 | 1-(4-((4-((3-(hydroxy- me...)
Affinity DataIC50: 740nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'SVD',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557885(US11365189, Ex. No. 21 | 1-(4-((4-((3-(hydroxy- me...)
Affinity DataIC50: 1.10E+4nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-770,'NPG',771-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557885(US11365189, Ex. No. 21 | 1-(4-((4-((3-(hydroxy- me...)
Affinity DataIC50: 4.10E+3nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SVD',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557885(US11365189, Ex. No. 21 | 1-(4-((4-((3-(hydroxy- me...)
Affinity DataIC50: 1.10E+4nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-769,'SV',770-1210](Human)
University Of Texas

US Patent
LigandPNGBDBM557885(US11365189, Ex. No. 21 | 1-(4-((4-((3-(hydroxy- me...)
Affinity DataIC50: 1.10E+4nMAssay Description:Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent